Nuvectis Pharma Inc. (NVCT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Nuvectis Pharma Inc.

    NASDAQ: NVCT · Real-Time Price · USD
    6.52
    0.17 (2.68%)
    At close: Sep 04, 2025, 3:59 PM
    6.65
    1.99%
    After-hours: Sep 04, 2025, 04:51 PM EDT

    Nuvectis Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 149K n/a
    Cost of Revenue
    		 n/a 22.9M 19.23M 12.89M
    Gross Profit
    		 n/a -22.9M -19.09M -12.89M
    Operating Income
    		 -19.85M -22.9M -19.23M -12.89M
    Interest Income
    		 847K 637K 149K 4K
    Pretax Income
    		 -19M -22.26M -19.09M -12.89M
    Net Income
    		 -19M -22.26M -18.79M -12.89M
    Selling & General & Admin
    		 6.93M 7.52M 6.01M 3.35M
    Research & Development
    		 12.92M 15.38M 13.23M 9.54M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 19.85M 22.9M 19.23M 12.89M
    Interest Expense
    		 n/a n/a 149K n/a
    Selling & Marketing Expenses
    		 n/a 14K n/a n/a
    Cost & Expenses
    		 19.85M 22.9M 19.23M 12.89M
    Income Tax Expense
    		 n/a n/a -298K -4K
    Shares Outstanding (Basic)
    		 17.11M 15.56M 12.66M 12.72M
    Shares Outstanding (Diluted)
    		 17.11M 15.56M 12.66M 12.72M
    EPS (Basic)
    		 -1.11 -1.43 -1.48 -1.01
    EPS (Diluted)
    		 -1.11 -1.43 -1.48 -1.01
    EBITDA
    		 -19M -22.9M -19.23M -12.89M
    EBIT
    		 -19M -21.9M -19.09M -12.89M
    Depreciation & Amortization
    		 n/a -1M -1.2M -7.1M

    Add to Watchlist